Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Potential new drug targets may enhance the treatment of prostate cancer
Potential new drug targets may enhance the treatment of prostate cancer
The doctoral thesis of A.
Benefits of COVID-19 vaccines far outweigh very rare risk of Bell's palsy, Lancet study confirms
Benefits of COVID-19 vaccines far outweigh very rare risk of Bell's palsy, Lancet study confirms
The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh th...
GSK receives FDA accelerated approval for JEMPERLI (dostarlimab-gxly) for adult patients with mismatch repair-deficient (dMMR) recurrent or advanced solid tumours
GSK receives FDA accelerated approval for JEMPERLI (dostarlimab-gxly) for adult patients with mismatch repair-deficient (dMMR) recurrent or advanced solid tumours
GlaxoSmithKline (GSK) plc today announced the US Food and Drug Administration (FDA) approved a new indication for JEMPERLI (dostarlimab-gxly), a programmed cell death receptor-...
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug
In a patent infringement lawsuit filed against Eli Lilly, Teva Pharmaceutical won three and lost six patents.
Serum Institute of India acquires 50% stake of SCHOTT Kaisha
Serum Institute of India acquires 50% stake of SCHOTT Kaisha
Serum Institute of India has bought 50% stake in the Indian joint venture SCHOTT Kaisha from former co-owners Kairus Dadachanji and Shapoor Mistry.
Merck's VHL Drug Becomes First-Ever HIF-2α Inhibitor Approved in U.S.
Merck's VHL Drug Becomes First-Ever HIF-2α Inhibitor Approved in U.S.
Merck won U.
Bimekizumab new results in psoriasis pave way for potential best in class, says GlobalData
Bimekizumab new results in psoriasis pave way for potential best in class, says GlobalData
UCB, a global biopharmaceutical company, has recently presented new interim data from BE BRIGHT, an open-label extension (OLE) trial of an interleukin (IL)-17A/F inhibitor ‘bimekizum...
NICE approval for Lilly's Verzenios is “fantastic news for thousands of women”
NICE approval for Lilly's Verzenios is “fantastic news for thousands of women”
After being rejected for routine use by the UK's NHS in February, Eli Lilly’s Verzenios (abemaciclib) has now been given the green light by health technology body, NICE.
FDA approves TicoVac™ tick-borne encephalitis (TBE) vaccine
FDA approves TicoVac™ tick-borne encephalitis (TBE) vaccine
The FDA has approved Ticovac, a tick-borne encephalitis (TBE) vaccine, for people aged one year and older when travelling to TBE endemic areas.
Lilly's lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials
Lilly's lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials
INDIANAPOLIS, Aug.
EMA starts evaluating use of RoActemra in hospitalised adults with severe COVID-19
EMA starts evaluating use of RoActemra in hospitalised adults with severe COVID-19
EMA has started evaluating the anti-inflammatory medicine RoActemra (tocilizumab) to extend its use to include treatment of hospitalised adult patients with severe COVID-19 who are already rec...
MHRA nod for Janssen’s relapsing multiple sclerosis drug Ponvory
MHRA nod for Janssen’s relapsing multiple sclerosis drug Ponvory
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Ponvory (ponesimod) for the treatment relapsing multiple sclerosis (RMS).
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand